AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcus Biosciences, Inc. Director's Dealing 2020

May 26, 2020

31966_dirs_2020-05-26_dc708713-d243-4a23-81c1-beac1116f4e9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2020-05-21

Reporting Person: Lacey David L. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	35352	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$10.23	2030-01-17	Common Stock (5000)		Direct

Footnotes

F1: The option is exercisable in 24 equal monthly installments after January 1, 2020, subject to the Reporting Person's continued service to the Company.